A PROPENSITY SCORE WEIGHTED COMPARISON OF VEDOLIZUMAB AND ADALIMUMAB IN CROHN'S DISEASE: REAL-LIFE DATA FROM THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASE (SN-IBD)

This article has no abstract
Epistemonikos ID: 09415defca481de3e867240fc1022914c608a84f
First added on: Feb 13, 2025